Sight Sciences Inc
NASDAQ:SGHT
Sight Sciences Inc
NASDAQ:SGHT
Price:
3.62
USD
-2.16%
Market Closed
Market Cap:
$191.4m
Balance Sheet
Balance Sheet Decomposition
Sight Sciences Inc
Sight Sciences Inc
Balance Sheet Decomposition is not available for
Sight Sciences Inc
Sight Sciences Inc
Balance Sheet
Sight Sciences Inc
Sight Sciences Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
4
|
21
|
62
|
261
|
185
|
138
|
120
|
92
|
|
| Cash Equivalents |
4
|
21
|
62
|
261
|
185
|
138
|
120
|
92
|
|
| Total Receivables |
2
|
4
|
5
|
9
|
15
|
14
|
11
|
10
|
|
| Accounts Receivables |
2
|
4
|
5
|
9
|
15
|
14
|
11
|
10
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
2
|
3
|
4
|
6
|
8
|
6
|
8
|
|
| Other Current Assets |
1
|
0
|
1
|
4
|
3
|
3
|
2
|
3
|
|
| Total Current Assets |
7
|
28
|
71
|
277
|
210
|
163
|
140
|
113
|
|
| PP&E Net |
1
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
|
| PP&E Gross |
1
|
3
|
2
|
3
|
3
|
3
|
3
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
8
N/A
|
31
+279%
|
73
+137%
|
280
+285%
|
213
-24%
|
167
-22%
|
143
-14%
|
115
-19%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
|
| Accrued Liabilities |
1
|
5
|
7
|
10
|
15
|
8
|
14
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Current Liabilities |
3
|
7
|
9
|
14
|
18
|
12
|
15
|
11
|
|
| Long-Term Debt |
0
|
13
|
32
|
33
|
33
|
32
|
39
|
40
|
|
| Other Liabilities |
0
|
1
|
3
|
2
|
2
|
2
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
21
+631%
|
44
+109%
|
48
+9%
|
53
+10%
|
46
-12%
|
55
+19%
|
51
-7%
|
|
| Equity | |||||||||
| Common Stock |
34
|
64
|
117
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
30
|
55
|
90
|
153
|
239
|
295
|
346
|
385
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
385
|
399
|
415
|
434
|
449
|
|
| Total Equity |
5
N/A
|
10
+85%
|
29
+197%
|
232
+714%
|
160
-31%
|
120
-25%
|
88
-27%
|
64
-27%
|
|
| Total Liabilities & Equity |
8
N/A
|
31
+279%
|
73
+137%
|
280
+285%
|
213
-24%
|
167
-22%
|
143
-14%
|
115
-19%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
45
|
45
|
45
|
48
|
48
|
49
|
51
|
53
|
|
Switch to:
Switch to:
See Also
Discover More
